Literature DB >> 15908686

In vitro drug resistance versus chemosensitivity: two sides of different coins.

John P Fruehauf, David S Alberts.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15908686     DOI: 10.1200/JCO.2005.05.281

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Five-year survival of metastatic pancreatic carcinoma: a study of courage and hope.

Authors:  Ben M Chue
Journal:  Gastrointest Cancer Res       Date:  2009-09

2.  Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients.

Authors:  Gregory Lucien Bellot; Wei Han Tan; Ling Lee Tay; Dean Koh; Xueying Wang
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-21       Impact factor: 4.553

3.  The role of in vitro directed chemotherapy in epithelial ovarian cancer.

Authors:  J Stuart Ferriss; Laurel W Rice
Journal:  Rev Obstet Gynecol       Date:  2010

Review 4.  Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.

Authors:  Molly M Morgan; Brian P Johnson; Megan K Livingston; Linda A Schuler; Elaine T Alarid; Kyung E Sung; David J Beebe
Journal:  Pharmacol Ther       Date:  2016-05-21       Impact factor: 12.310

Review 5.  Current status of methods to assess cancer drug resistance.

Authors:  Theodor H Lippert; Hans-Jörg Ruoff; Manfred Volm
Journal:  Int J Med Sci       Date:  2011-03-23       Impact factor: 3.738

Review 6.  Prediction of individual response to anticancer therapy: historical and future perspectives.

Authors:  Florian T Unger; Irene Witte; Kerstin A David
Journal:  Cell Mol Life Sci       Date:  2014-11-12       Impact factor: 9.261

7.  Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer.

Authors:  C W Michalski; M Erkan; D Sauliunaite; T Giese; R Stratmann; C Sartori; N A Giese; H Friess; J Kleeff
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

8.  Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial).

Authors:  Nobuhiko Tanigawa; Hiroki Yamaue; Shigekazu Ohyama; Shinichi Sakuramoto; Takao Inada; Yasuhiro Kodera; Yuko Kitagawa; Kenji Omura; Masanori Terashima; Yuh Sakata; Atsushi Nashimoto; Toshiharu Yamaguchi; Keisho Chin; Eiji Nomura; San-Woong Lee; Masahiro Takeuchi; Masashi Fujii; Toshifusa Nakajima
Journal:  Gastric Cancer       Date:  2015-09-18       Impact factor: 7.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.